168 related articles for article (PubMed ID: 15251739)
21. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.
Wall JR; Bernard N; Boucher A; Salvi M; Zhang ZG; Kennerdell J; Tyutyunikov A; Genovese C
Clin Immunol Immunopathol; 1993 Jul; 68(1):1-8. PubMed ID: 8513588
[TBL] [Abstract][Full Text] [Related]
22. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
23. Antibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a full length 64 kDa eye muscle membrane protein which is also expressed in the thyroid.
Zhang ZG; Dong Q; Rodien P; Alcalde L; Bernard N; Boucher A; Salvi M; Arthurs B; Vassart GM; Ludgate M
Autoimmunity; 1992; 13(2):151-7. PubMed ID: 1467436
[TBL] [Abstract][Full Text] [Related]
24. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Mizokami T; Salvi M; Wall JR
J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
[TBL] [Abstract][Full Text] [Related]
25. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
28. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.
Wall JR; Triller H; Boucher A; Bernard NF; Salvi M; Ludgate M
J Endocrinol Invest; 1993 Dec; 16(11):863-8. PubMed ID: 7511621
[TBL] [Abstract][Full Text] [Related]
29. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.
Yamada M; Li AW; Wall JR
Crit Rev Clin Lab Sci; 2000 Dec; 37(6):523-49. PubMed ID: 11192331
[TBL] [Abstract][Full Text] [Related]
30. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot.
Hiromatsu Y; Sato M; Tanaka K; Shoji S; Nonaka K; Chinami M; Fukazawa H
Autoimmunity; 1992; 14(1):9-16. PubMed ID: 1299352
[TBL] [Abstract][Full Text] [Related]
31. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting.
Bernard NF; Ertug F; Teboul N; Zhang ZG; Salvi M; Wall JR
Autoimmunity; 1991; 10(1):57-63. PubMed ID: 1742423
[TBL] [Abstract][Full Text] [Related]
32. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
33. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
[TBL] [Abstract][Full Text] [Related]
36. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
37. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.
Mengistu M; Laryea E; Miller A; Wall JR
Clin Exp Immunol; 1986 Jul; 65(1):19-27. PubMed ID: 3539423
[TBL] [Abstract][Full Text] [Related]
39. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
40. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR
Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
